Infinity Pharmaceuticals Investor Relations Material
Latest events
Investor Update
Infinity Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Infinity Pharmaceuticals Inc
Access all reports
Infinity Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer. The company's research primarily targets the immune system to enhance the body's ability to fight cancer. Infinity’s lead drug candidates aim to treat various types of solid tumors by modulating key immune pathways and working in combination with other therapies to improve patient outcomes. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
INFI
Country
🇺🇸 United States